Tempus AI Inc. (TEM) experienced a significant intraday decline, with its stock price plummeting 5.08% on Thursday. The drop occurred during regular trading hours, marking a sharp reversal for the AI-enabled precision medicine company.

The decline is attributed to profit-taking activity following the company's recent strong first-quarter earnings report. Despite beating revenue and earnings expectations, the stock had already surged over 10% ahead of the report on optimism in the AI healthcare sector. The official release of the positive results triggered a classic "buy-the-rumor, sell-the-news" pattern as investors locked in gains.

Concurrently, the company announced a proposed private offering of $350 million in convertible senior notes due 2032. Market analysts noted that the planned capital raise pressured the stock price in pre-market and intraday trading, as such offerings often raise concerns about potential future dilution for existing shareholders. The proceeds are earmarked to repay outstanding debt and fund general corporate purposes.